Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · IEX Real-Time Price · USD
8.97
-0.28 (-3.03%)
At close: Jul 2, 2024, 4:00 PM
9.10
+0.13 (1.45%)
After-hours: Jul 2, 2024, 5:39 PM EDT
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $492.57 million as of July 2, 2024. Its market cap has increased by 75.23% in one year.
Market Cap
492.57M
Enterprise Value
122.83M
1-Year Change
75.23%
Ranking
Category
Stock Price
$8.97
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $492.57M, an increase of 173.65%. That is a compound annual growth rate of 11.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 507.90M | 82.17% |
Dec 29, 2023 | 278.80M | 11.30% |
Dec 30, 2022 | 250.50M | 257.35% |
Dec 31, 2021 | 70.10M | 63.02% |
Dec 31, 2020 | 43.00M | -38.31% |
Dec 31, 2019 | 69.70M | 124.84% |
Dec 31, 2018 | 31.00M | -9.88% |
Dec 29, 2017 | 34.40M | -48.89% |
Dec 30, 2016 | 67.30M | -44.52% |
Dec 31, 2015 | 121.30M | -32.61% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Y-mAbs Therapeutics | 519.13M |
ORIC Pharmaceuticals | 515.11M |
Lexeo Therapeutics | 514.28M |
Altimmune | 510.50M |
Mereo BioPharma Group | 509.18M |
Sharecare | 502.47M |
KalVista Pharmaceuticals | 501.62M |
Mind Medicine (MindMed) | 498.44M |